Nutritional compositions for human consumption and methods for making same
US-2024216434-A1 · Jul 4, 2024 · US
US9089533B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9089533-B2 |
| Application number | US-201013321499-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 19, 2010 |
| Priority date | May 19, 2009 |
| Publication date | Jul 28, 2015 |
| Grant date | Jul 28, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to human milk fortifiers comprising high protein content and long chain poly-unsaturated fatty acids. Use of such human milk fortifier improves the body adipose tissue distribution by increasing the subcutaneous adipose tissue mass, while at the same time not increasing visceral adipose tissue.
Opening claim text (preview).
The invention claimed is: 1. A method of decreasing the ratio visceral adipose tissue to subcutaneous adipose tissue in preterm infants and infants small for gestational age, the method comprising: (a) mixing human milk with a human milk fortifier, comprising: (i) at least 20% protein based on total calories, (ii) at least 5% fat based on total calories, wherein the fat comprises from 0.15 wt. % to 4 wt. % docosahexaenoic acid based on total fatty acids, to produce a fortified human milk, and (b) administering the fortified human milk to a preterm infant or infant small for gestational age in need thereof, wherein administration of the fortified human milk results in growth without development of excess visceral adipose tissue. 2. The method according to claim 1 , comprising administering 0.1 -20 g dry weight of the human milk fortifier per day. 3. The method according to claim 1 , wherein the infant is small for gestational age. 4. A method of promoting catch up growth in infants small for gestational age, the method comprising: (a) mixing human milk with a human milk fortifier, comprising: (i) at least 20% protein based on total calories, (ii) at least 5% fat based on total calories, wherein the fat comprises from 0.15 wt. % to 4 wt. % docosahexaenoic acid based on total fatty acids, to produce a fortified human milk, and (b) administering the fortified human milk to an infant small for gestational age in need thereof, wherein administration of the fortified human milk results in growth without development of excess visceral adipose tissue. 5. The method according to claim 4 , comprising administering 0.1 -20 g dry weight of the human milk fortifier per day.
Cyclic peptides {, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C (A61K38/043 - A61K38/046 take precedence)} · CPC title
Polyunsaturated fatty acids · CPC title
Docosahexaenoic acid · CPC title
Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title
Fatty acids or derivatives thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.